WO2003065947A1 - Stiffening pharyngeal wall treatment - Google Patents

Stiffening pharyngeal wall treatment Download PDF

Info

Publication number
WO2003065947A1
WO2003065947A1 PCT/US2003/003503 US0303503W WO03065947A1 WO 2003065947 A1 WO2003065947 A1 WO 2003065947A1 US 0303503 W US0303503 W US 0303503W WO 03065947 A1 WO03065947 A1 WO 03065947A1
Authority
WO
WIPO (PCT)
Prior art keywords
airway
implant
pharyngeal
wall
pharyngeal wall
Prior art date
Application number
PCT/US2003/003503
Other languages
French (fr)
Inventor
Anja K. Metzger
Brian J. Erickson
John P. Sopp
Mark B. Knudson
Timothy R. Conrad
Original Assignee
Restore Medical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/066,967 external-priority patent/US7146981B2/en
Application filed by Restore Medical, Inc. filed Critical Restore Medical, Inc.
Priority to AU2003209005A priority Critical patent/AU2003209005A1/en
Publication of WO2003065947A1 publication Critical patent/WO2003065947A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/56Devices for preventing snoring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/20Epiglottis; Larynxes; Tracheae combined with larynxes or for use therewith
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/046Tracheae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Definitions

  • Fig. 9 is a view similar to that of Fig. 6 showing multiple devices placed in the pharyngeal wall and oriented parallel relative to a longitudinal axis of the air passage;
  • Fig. 10 is a cross-sectional view taken along section line 10-10 of Fig. 9;
  • Fig. 11 is a view similar to that of Fig. 6 with a sheet placed in the pharyngeal wall.
  • Fiberoptic endoscopy with or without the M ⁇ ller maneuver has been shown to be able to effectively define the pattern and location of pharyngeal collapse in children. Fairbanks, supra, Ref. No. 42, p. 29. However, contrasting literature claims that the M ⁇ ller maneuver has not been demonstrated to accurately simulate an apneic event during sleep (Schwab RJ, Upper Airway Imaging. Clinics in Chest Medicine 1998; 19(l):33-54) and proposes that that a combination of MR imaging and nasopharyngoscopy with a M ⁇ ller maneuver prior to UPPP may improve outcome after surgery.

Abstract

A pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining the airway is treated by selecting an implant (110, 110', 110'') dimensioned so as to be implanted at or beneath a mucosal layer of the pharyngeal wall and extending transverse to said wall. The implant (110, 110', 110'') has mechanical characteristics for the implant, at least in combination with a fibrotic tissue response induced by the implant, to stiffen said pharyngeal wall to resist radial collapse. The implant is implanted into the pharyngeal wall transverse to a longitudinal axis of the airway.

Description

STIFFENING PHARYNGEAL WALL TREATMENT
This application is being filed as a PCT International Patent application in the name of Restore Medical, Inc., a U.S. national corporation, applicant for the designation of all countries except the US, on 4 February 2003.
BACKGROUND
1. Field of the Invention
This invention is directed to methods and apparatuses for treating the pharyngeal wall of a patient. More particularly, this invention pertains to method and apparatus for treating a pharyngeal wall area as part of a sleep apnea treatment.
2. Description of the Prior Art
Sleep apnea and snoring are complex phenomena. Commonly assigned U.S. Pat. No. 6,250,307 describes various prior techniques and discloses a novel treatment for such conditions (including a permanent palatal implant).
These prior art teachings include Huang, et al., "Biomechanics of Snoring", Endeavour, p. 96 - 100, Vol. 19, No. 3 (1995). That publication estimates that up to 20% of the adult population snores habitually. Snoring can be a serious cause of marital discord. In addition, snoring can present a serious health risk to the snorer. In 10% of habitual snorers, collapse of the airway during sleep can lead to obstructive sleep apnea syndrome. Id. In addition to describing a model for palatal flutter, that publication also describes a model for collapse of the pharyngeal wall. Notwithstanding efforts have been made to treat snoring and sleep apnea. These include palatal treatments such as electrical stimulation of the soft palate. See, e.g., Schwartz, et al., "Effects of electrical stimulation to the soft palate on snoring and obstructive sleep apnea", J. Prosthetic Dentistry, pp. 273 - 281 (1996). Devices to apply such stimulation are described in U.S. Pat. Nos. 5,284,161 and 5,792,067. Such devices are appliances requiring patient adherence to a regimen of use as well as subjecting the patient to discomfort during sleep. Electrical stimulation to treat sleep apnea is discussed in Wiltfang, et al., "First results on daytime submandibular electro stimulation of suprahyoidal muscles to prevent nighttime hypopharyngeal collapse in obstructive sleep apnea syndrome", International Journal of Oral & Maxillofacial Surgery, pp. 21 - 25 (1999). Surgical treatments for the soft palate have also been employed. One such treatment is uvulopalatopharyngoplasty (UPPP) where about 2 cm of the trailing edge of the soft palate is removed to reduce the soft palate's ability to flutter between the tongue and the pharyngeal wall of the throat. See, Huang, et al., supra at 99 and Harries, et al., "The Surgical treatment of snoring", Journal of Laryngology and Otology, pp. 1105 - 1106 (1996) which describes removal of up to 1.5 cm of the soft palate. Assessment of snoring treatment is discussed in Cole, et al, "Snoring: A review and a Reassessment", Journal of Otolaryngology, pp. 303 - 306 (1995). Huang, et al., propose an alternative to UPPP which proposal includes using a surgical laser to create scar tissue on the surface of the soft palate. The scar is to reduce flexibility of the soft palate to reduce palatal flutter. RF ablation (so- called Somnoplasty as advocated by Somnus Technologies) is also suggested to treat the soft palate. RF ablation has also been suggested for ablation of the tongue base. In pharyngeal snoring and sleep apnea, the pharyngeal airway collapses in an area between the soft palate and the larynx. One technique for treating airway collapse is continuous positive airway pressure (CPAP). In CPAP air is passed under pressure to maintain a patent airway. However, such equipment is bulky, expensive and generally restricted to patients with obstructive sleep apnea severe enough to threaten general health. Huang, et al. at p. 97.
Treatments of the pharyngeal wall include electrical stimulation is suggested in U.S. Pat. No. 6,240,316 to Richmond et al. issued May 29, 2001, U.S. Pat. No. 4,830,008 to Meer issued May 16, 1989, U.S. Pat. No. 5,158,080 to Kallok issued October 27, 1992, U.S. Pat. No. 5,591,216 to Testerman et al. issued January 7, 1997 and PCT International Publication No. WO 01/23039 published April 5, 2001 (on PCT International Application No. PCT/USOO/26616 filed September 28, 2000 with priority to U.S. Ser. No. 09/409,018 filed September 29, 1999). U.S. Pat. No. 5,979,456 to Magovern dated November 9, 1999 teaches an apparatus for modifying the shape of a pharynx. These teachings include a shape-memory structure having an activated shape and a quiescent shape. Dreher et al., "Influence of nasal obstruction on sleep-associated breathing disorders", So. Laryngo-Rhino-Otologie, pp. 313 - 317 (June 1999), suggests using nasal stents to treat sleep associated breathing disorders involving nasal obstruction. Upper airway dilating drug treatment is suggested in Aboubakr, et al., "Long-term facilitation in obstructive sleep apnea patients during NREM sleep", J. Applied Physiology, pp. 2751 - 2757 (December 2001).
Surgical treatments for sleep apnea are described in Sher et al., "The Efficacy of Surgical Modifications of the Upper Airway in Adults with Obstructive Sleep Apnea Syndrome", Sleep, Vol. 19, No. 2, pp. 156 - 177 (1996). Anatomical evaluation of patients with sleep apnea or other sleep disordered breathing are described in Schwab, et al., "Upper Airway and Soft Tissue Anatomy in Normal Subjects and Patients with Sleep-Disordered Breathing", Am. J. Respir. Crit. Care Med., Vol. 152, pp. 1673 - 1689 (1995) ("Schwab I") and Schwab et al., "Dynamic Upper Airway Imaging During Awake Respiration in Normal Subjects and Patients with Sleep Disordered Breathing", Am. Rev. Respir. Pis., Vol. 148, pp. 1385 - 1400 (1993) ("Schwab II). In Schwab I, it is noted that apneic patients have a smaller airway size and width and a thicker lateral pharyngeal wall. For reviews of pharyngeal wall thickness and other structure and obstructive sleep apnea, see, also, Wheatley, et al., "Mechanical Properties of the Upper Airway", Current Opinion in Pulmonary Medicine, pp. 363 - 369 (November 1998); Schwartz et al., "Pharyngeal airway obstruction in obstructive sleep apnea: pathophysiology and clinical implication", Otolaryngologic Clinics of N. Amer., pp. 911 - 918 (December 1998); Collard, et al, "Why should we enlarge the pharynx in obstructive sleep apnea?", Sleep, (9 Suppl.) pp. S85 - S87 (November 1996); Winter, et al., "Enlargement of the lateral pharyngeal fat pad space in pigs increases upper airway resistance", J. Applied Physiology, pp. 726 - 731 (September 1995); and Stauffer, et al., "Pharyngeal Size and Resistance in Obstructive Sleep Apnea", Amer. Review of Respiratory Disease, pp. 623 - 627 (September 1987).
There are contrasting opinions in the medical literature on the mechanisms of OSA. OSA patients are a heterogeneous group; there are differing locations and patterns of pharyngeal collapse for each person. In addition to the physical findings and properties which characterize the pharynx in patients with OSA such as increased coUapsibihty, increased compliance, increased resistance, and decreased cross-sectional area, the physical properties and spatial relationships of the pharyngeal airway, head, and neck, as well as the neuromuscular integrity of the airway (reflexes affecting upper airway caliber) and mechanisms of breathing control (pharyngeal inspiratory muscle function) must also be considered relevant in their contribution to the mechanism and precipitation of upper airway collapse. Hudgel DW, Mechanisms of Obstructive Sleep Apnea. Chest 1992; 101:541-49. Fairbanks DNF, Fujita S, Snoring and Obstructive Sleep Apnea. Raven Press Ltd., New York, 1994.
In general, obstructive apnea occurs during sleep, when the pharyngeal dilator muscle activity (genioglossus, tensor palatini, geniohyoid, stylohyoid) that normally maintains airway patency during inspiration through dilation of the airway, is diminished. (Fairbanks DNF, Fujita S, Snoring and Obstructive Sleep Apnea. Raven Press Ltd., New York, 1994.2, p. 85). When the intraluminal negative pressure of the airway reaches a critical point, the combination of redundant tissues and the loss of pharyngeal muscle tone causes airway collapse during inspiration. Please note, obstruction has been shown to occur during expiration and inspiration (Schwab RJ et al., Dynamic imaging of the upper airway during respiration in normal subjects. J Appl Physiol 1993 ; 74(4): 1504- 1514. Schwab RJ, Functional Properties of the Pharyngeal Airway. Sleep 1996; 19(10):S170-S174. 8, 9); details on how upper airway area changes during the respiratory cycle can be found in the cited literature. Surgical treatments are aimed at eliminating any collapsible tissue in the airway and reducing airway resistance without creating functional impairment of the upper airway structures.
SUMMARY OF THE INVENTION According to one aspect of the present invention, methods and apparatuses are disclosed for treating a pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining said airway. The method includes selecting an implant dimensioned so as to be implanted beneath a mucosal layer of the pharyngeal wall and extending transverse to said wall. The implant has mechanical characteristics for the implant, at least in combination with a fibrotic tissue response induced by the implant, to stiffen aid pharyngeal wall to resist radial collapse. The implant is implanted into the pharyngeal wall transverse to a longitudinal axis of the airway.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 shows, in cross-section, a naso-pharyngeal area of an untreated patient;
Fig. 2 is the view of Fig. 1 with the soft palate containing an implant in the form of a bolus of micro-beads deposited in a linear path;
Fig. 3 is a frontal view of the patient of Fig. 3 showing an alternative embodiment with micro-beads deposited as spherical deposits; Fig. 4 is a schematic representation showing a patch for delivering a bolus of micro-beads through a plurality of needles;
Fig. 5 is a schematic cross-sectional view (taken generally along line 5 - 5 in Fig. 1) of a pharyngeal airway at a position in a person with the airway defined by opposing portions of a pharyngeal wall and a base of a tongue; Fig. 6 is a view similar to that of Fig. 1 (only showing patient's right side) with a device according to the present invention placed in the pharyngeal wall and with the pharyngeal wall and the device shown in perspective for ease of illustration; Fig. 7 is a cross-sectional view taken along section line 7-7 of Fig. 6; Fig. 8 is a view similar to that of Fig. 6 showing multiple devices placed in the pharyngeal wall;
Fig. 9 is a view similar to that of Fig. 6 showing multiple devices placed in the pharyngeal wall and oriented parallel relative to a longitudinal axis of the air passage; Fig. 10 is a cross-sectional view taken along section line 10-10 of Fig. 9; and Fig. 11 is a view similar to that of Fig. 6 with a sheet placed in the pharyngeal wall.
DESCRIPTION OF THE PREFERRED EMBODIMENT
A. Physiology Background
Referring now to the several drawing figures, in which identical elements are numbered identically throughout, a description of a preferred embodiment of the present invention will now be provided. The disclosures of U. S. Pat. No. 6,250,307 and PCT International
Publications No. WO 01/19301 (PCT/US00/40830) and WO 02/13738 (PCT/US01/24255) are incorporated herein by reference.
Fig. 1 shows, in cross-section, a naso-pharyngeal area of an untreated patient. Fig. 1 shows the nose N, mouth M and throat TH. The tongue T is shown in an oral cavity OC of the mouth. A hard palate HP (containing a bone B) separates the oral cavity OC from the nasal cavity NC. The nasal concha C (soft tissue which defines, in part, the nasal sinus - not shown) resides in the nasal cavity NC.
The soft palate SP (a muscle activated soft tissue not supported by bone) depends in cantilevered manner at a leading end LE from the hard palate HP and terminates at a trailing end TE. Below the soft palate SP, the pharyngeal wall PW defines the throat passage TP. A nasal passage NP connects the nasal cavity NC to the pharyngeal wall PW. Below an epiglottis EP, the throat passage TP divides into a trachea TR for passing air to the lungs and an esophagus ES for passing food and drink to the stomach. The soft palate SP is operated by muscles (not separately shown and labeled) to lift the soft palate SP to urge the trailing edge TE against the rear area of the pharyngeal wall PW. This seals the nasal cavity NC from the oral cavity OC during swallowing. The epiglottis EP closes the trachea TR during swallowing and drinking and opens for breathing. For purposes of this disclosure, the nasal cavity NC, oral cavity OC and throat passage TP are collectively referred to as the naso-pharyngeal area of the patient (defining, in part, the pharyngeal airway PA in Figs. 5 and 7) with the area including the various body surfaces which cooperate to define the nasal cavity NC, oral cavity OC and throat passage TP. These body surfaces include outer surfaces of the nasal concha C, the upper and lower surfaces of the soft palate SP and outer surfaces of the pharyngeal wall PW. Outer surfaces means surfaces exposed to air. Both the upper and lower surfaces of the soft palate SP are outer surfaces. Snoring can result from vibration of any one of a number of surfaces or structures of the naso-pharyngeal area. Most commonly, snoring is attributable to vibration of the soft palate SP. However, vibratory action of the nasal concha C and the pharyngeal wall PW can also contribute to snoring sounds. It is not uncommon for vibratory action from more than one region of the naso-pharyngeal area to contribute to snoring sounds. Sleep apnea can result from partial or full collapse of the naso-pharyngeal wall during sleep.
Fig. 5 shows a schematic representation of a cross-section of a throat with the pharyngeal airway PA defined by the pharyngeal wall PW and the tongue T. The anterior-posterior axis is labeled A-P to assist in discerning the orientation. The pharyngeal wall PW is shown as including the left lateral pharyngeal wall LLPW, right lateral pharyngeal wall RLPW and posterior pharyngeal wall PPW.
B. Disclosure of Commonly Assigned Applications In addition to disclosing the teachings of U.S. Pat. No. 6,250,307 and the teachings of selected embodiments of PCT International Publication Nos. WO 01/19301 (both incorporated herein by reference), commonly assigned and co- pending PCT International Publication No. WO 02/13738 (incorporated by reference) describes techniques for stiffening tissue of the pharyngeal airway with a bolus of particulate matter. Figs. 2 and 3 show are taken from International Publication No. WO 02/13738 and show an implant 10 as a bolus of particulate matter. An example of such particulate matter would be micro-beads. An example of such is taught in U.S. Pat. Nos. 5,792,478 and 5,421,406. These patents teach carbon-coated metallic or ceramic particles having cross-sectional dimensions of between 100 and 1,000 microns. The particles are carried in a fluid or gel. These patents state that upon insertion into body tissue, the particles do not migrate significantly and, apparently due to fibrotic response, the tissue into which the particles are injected stiffens.
The particles of U.S. Pat. Nos. 5,792,478 and 5,421,406 are one example of particles for stiffening injection. Such particles can also include ceramic particles or pure carbon or other bio-compatible particles. The particles can be carried in a liquid or gel medium. The particles can have multi-modal particle size distributions (i.e., a mix of two or more sizes of particles with the smaller particles filling interstitial spaces between larger particles). The bolus 10 of particles can be applied by a needle to inject the bolus 10 into the soft palate SP. The bolus can be the same volume as the volume of the implants 20 of Figs. 8 and 9 of U.S. Pat. No. 6,250,307. With reference to Fig. 3, a multiple of bolus injections can be made in the soft palate resulting in deposition of generally spherical deposits 10' of particles. Alternatively, an injecting needle can be withdrawn while simultaneously ejecting particles for the bolus 10 (Fig. 2) to be deposited in a line similar in dimensions to the implants 20 of Figs. 8 and 9 of U.S. Pat. No. 6,250,307. The foregoing emphasizes the use of implants to stiffen the soft palate SP.
Implants 10 can be placed in any of the tissue of the naso-pharyngeal area (e.g., the concha C, soft palate SP or pharyngeal wall PW) to treat snoring. Also, such a treatment can stiffen the tissue of the throat and treat sleep apnea resulting from airway collapse by stiffening the airway. While a needle deposition of a bolus of particles may be preferred, the bolus can be applied in other manners. Fig. 4 illustrates deposition of particulates through a patch 200 having a volume 202 containing such micro-beads 204.
One side 200a of the patch 200 contains an array of micro-needles 206 communicating with the volume 202. The needles 206 may be small diameter, shallow penetration needles to minimize pain and blood. Examples of shallow, small diameter needles are shown in U.S. Pat. No. 5,582,184 to Erickson et al. Placing the surface 200a against the tissue (e.g., the pharyngeal wall PW as shown in Fig. 4), the needles 206 penetrate the outer surface of the tissue PW. The patch 200 can then be compressed (by finger pressure, roller or the like) to eject the beads 204 from the volume 200 through the plurality of needles 206. The patch 200 can be provided with interior dividing walls (not shown) so that some of the volume of beads 204 is ejected through each needle 206. The side 200a acts as a stop surface to ensure control over the penetration depth of the needles 206 to reduce risk of undesired puncture of underlying structures. Stiffening of the naso-pharyngeal tissue provides structure to reduce vibration and snoring. Such structure reduces airway collapse as a treatment for sleep apnea. Commonly assigned and co-pending U.S. Pat. Application Ser. No. 10/066,967 filed February 4, 2002 teaches stiffening of the pharyngeal wall with other stiffening techniques including pre-compressϊng the wall and stiffening the wall in a compressed state.
C. Transverse Stiffening Implant
Figs. 6 - 7 illustrate the device of the present invention in a pharyngeal wall. As will be further discussed, the implant can be placed at any location along the length of the airway to stiffen the posterior and lateral walls of the pharyngeal wall. While only one implant is shown in Figs. 6 - 7, multiple implants 100 can be placed in the pharyngeal wall as shown in Figure 8. The device is an implant 110 of biocompatible material selected to induce a fibrotic tissue response. A preferred device is a flexible braid 110 of polyester fibers. In a preferred design, the implant 110 has a diameter of about 2 mm. A length of 10 mm to 20 mm (depending on patient) can cover about 180 degrees surrounding the pharyngeal airway PA. In one embodiment, the implant is elastic so as to be biased toward an at rest position following bending the implant along its longitudinal axis.
The braided implant 110 is preferably formed of a plurality of fibers of similar material (i.e., all polyester fibers). The fibers are bonded together near the ends 112 of the braid to prevent excessive fraying.
The braid 110 may be a simple braid (such as that shown in International Publication No. WO 01/19301 Al (PCT US00/40830)) or may be any other braid geometry such as so-called three dimensional braids as described in Du et al., "Geometric Modeling of 3-D Braided Preforms For Composites", Proceedings of 5th Textile Structural Composites Symposium, Drexel University, Philadelphia, PA (1991) and Ko et al., "Braiding", Engineering Materials Handbook, Vol. 1, Composites, Reinhart, T.J. Editor, ASM International, Metal Park, OH pp. 519 — 528 (1988). An example of such a more complex braid is shown in commonly assigned and co-pending U.S. patent application Ser. No. 09/814,471 filed March 21, 2001 and filed internationally as PCT/US02/07966 on March 14, 2002, that is hereby incorporated by reference in its entirety.
According to the '471 application, such a 3-D braid could be a 1X1 3-D braid formed on a 24-carrier machine with a braiding angle of 45 degrees and a braid diameter of about 2 mm. The braid is formed of 24 braider yarns of 70 denier yarns with 2 denier/fil (air-textured yarns may be substituted as discussed below). The braid can be formed with 8 axial polyester yarns of 400 denier (7.9 - 8 mil) monofilament. While a core-less braid is preferred, cores can be added for stiffness. Such cores may be 10 mono filaments of polyester at 400 denier per filament. It will be appreciated that 3-D braid construction as described form no part of this invention per se and may be formed as described in the afore-mentioned articles.
In a preferred embodiment of a braid as disclosed in the '471 application, the fibers are heat bonded together (e.g., by application of ultrasonic energy) at two locations spaced 1 mm from the ends of the braid. The ends then be frayed for the individual fibers to splay freely from the bonded locations at the ends. The bonded locations insure the fraying does not migrate throughout the entire length of the braid. As an alternative to fraying, the ends may be left braided but unbonded. The ends are then free to fray with the bonded locations insuring any such fraying does not migrate. With the structure of a braid as disclosed in the '471 application and as described above, the frayed ends present a softened tip to tissue as compared to un- frayed ends of an otherwise identical braid. The softened frayed ends reduce likelihood of migration of the braid in the tissue of the soft palate. The fibers of the braid may be air textured yarns so that the braid presents a plurality of fiber loops along its length, These loops present increased volume of interstitial space in the braid for increased tissue growth to further reduce the probability of migration of the braid in tissue. Not all of the fibers need be air- textured yarns. For example, 50% (or some different percentage) of the fibers can be un-textured (or straight) polyester fibers (or silk or other material) and the remaining 50% can be air-textured polyester fibers (or silk or other material). This ratio can be changed at a braid designer's convenience. Also, as an alternative embodiment, in the braid, air-textured fibers can be placed predominantly in the interior of the braid for a less stiff braid and more interior interstitial space for tissue in-growth.
The implant 110 is placed in the pharyngeal wall PW with the longitudinal axis of the braid 110 bending in the wall PW and extending transverse to the anterior-posterior axis A-P of the airway PA and also transverse relative to a longitudinal axis of the airway PA. The device 110 thus positioned wraps at least partially around the airway PW to reside in the posterior and lateral pharyngeal walls PPW, RLPW, LLPW.
Preferably, the implant is placed in or beneath a mucosal layer. The device can have a radiopaque marker 111 to assist in visualization of the implant during and after placement. With such marker, the device's position and influence on swallowing can be assessed, the device's effect on maintaining the airway patent at various inspiratory pressures can be visualized. The marker and implant should be magnetic resonance imaging (MRI) compatible.
The location of pharyngeal collapse in a patient is identified so that the device can be targeted for the most appropriate location in the pharynx. The majority of airway collapse is believed to occur in the retropalatal region because the airway narrowing has been shown to be greatest in the retropalatal region. Schwab RJ, Upper Airway Imaging. Clinics in Chest Medicine 1998; 19(l):33-54. This region is defined as the region from the level of the hard palate to the caudal tip of the soft palate (uvula). However, studies have also shown that collapse also occurs in the retroglossal region, defined from the caudal margin of the soft palate to the base of the epiglottis. See, e.g., Hudgel DW, Mechanisms of Obstructive Sleep Apnea. Chest 1992; 101:541-49. A body of literature indicates that the lateral pharyngeal walls, rather than the anterior-posterior walls of the pharynx, are the structures which mediate the changes in upper airway size in OSA. Schwab RJ, Upper Airway Imaging. Clinics in Chest Medicine 1998; 19(l):33-54; Trudo FJ et al, State-related Changes in Upper Airway Caliber and Surrounding Soft-Tissue Structures in Normal Subjects. Am J Respir Crit Care Med 1998; 158:1259-1270; Schwab RJ, Functional Properties of the Pharyngeal Airway. Sleep 1996; 19(10):S170-S174; Schwab RJ et al., Upper Airway and Soft Tissue Anatomy in Normal Subjects and Patients with Sleep- Disordered Breathing. Am J Respir Crit Care Med 1995; 152:1673-1689. Mϋller's maneuver with fiberoptic nasopharyngoscopy and cephalometric measurement are presently the key diagnostic tools used to identify the location of airway narrowing causing an apneic episode. See, Fairbanks DNF, Fujita S, Snoring and Obstructive Sleep Apnea. Raven Press Ltd., New York, 1994, p. 92. Fiberoptic endoscopy with or without the Mϋller maneuver has been shown to be able to effectively define the pattern and location of pharyngeal collapse in children. Fairbanks, supra, Ref. No. 42, p. 29. However, contrasting literature claims that the Mϋller maneuver has not been demonstrated to accurately simulate an apneic event during sleep (Schwab RJ, Upper Airway Imaging. Clinics in Chest Medicine 1998; 19(l):33-54) and proposes that that a combination of MR imaging and nasopharyngoscopy with a Mϋller maneuver prior to UPPP may improve outcome after surgery. For example, if the nasopharyngoscopy with Mϋller maneuver demonstrates retroglossal collapse and the MR imaging demonstrates primarily retroglossal narrowing, surgery directed at advancing the tongue such as geniohyoid advancement or maxillomandibular advancement should be considered rather than UPPP. Posterior pharyngeal wall movement is observed in swallowing. Jones B,
Donner MW, Normal and Abnormal Swallowing. Springer-Verlag, New York, 1991. Schwab has demonstrated that thickening of the lateral pharyngeal muscular walls is the major factor that leads to narrowing of the apneic retropalatal airway. Schwab RJ et al., Upper Airway and Soft Tissue Anatomy in Normal Subjects and Patients with Sleep-Disordered Breathing. Am J Respir Crit Care Med 1995; 152:1673-1689.
The basis for the increased thickness of the lateral pharyngeal walls in apneics is unknown. Experiments utilizing HUPSEC (Hydrogen Ultrathin Phase- Encoded Spectroscopy) in conjunction with MR imaging indicate that the increased thiclcness of lateral pharyngeal wall in patients with sleep apnea is not secondary to increased fat infiltration or edema.
Another plausible explanation for the thickening of the lateral walls is that weight gain results in increased muscle mass and an increase in the size of the lateral pharyngeal walls as well as the tongue and soft palate. Therefore, obesity may predispose to sleep apnea by theoretically increasing the size of the upper airway soft-tissue structures rather than by the direct deposition of fat in the parapharyngeal fat pads or by compressing the lateral airway walls by these fat pads. Studies have shown that the parapharyngeal fat pads do not compress the lateral airway walls in apneics. Schwab RJ et al, Upper Airway and Soft Tissue Anatomy in Normal Subjects and Patients with Sleep-Disordered Breathing. Am J Respir Crit Care Med 1995; 152:1673-1689.
Apneics have thicker lateral pharyngeal walls when they are awake and these structures become even thicker during sleep. Schwab RJ, Functional Properties of the Pharyngeal Airway. Sleep 1996; 19(10):S170-S174. Studies have demonstrated a decrease in the electromyographic activity of the muscles of the lateral pharyngeal walls during sleep as well as the tensor palatini muscle of the soft palate. Trudo FJ et al., State-related Changes in Upper Airway Caliber and Surrounding Soft-Tissue Structures in Normal Subjects. Am J Respir Crit Care Med 1998; 158:1259-1270; Wheatley et al, Influence of Sleep on Response to Negative Airway Pressure of Tensor Palatini Muscle and Retropalatal Airway. J Appl Physiol 1993; 75(5):21 17- 2124. The decrease in EMG activity may cause relaxation of these structures, contributing to the lateral wall thickening and airway narrowing. However, thickening of the lateral walls during sleep may be associated with state-related changes (asleep vs. awake) in the conformation of the soft palate and tongue.
A complex three-dimensional biomechanical interaction may exist between the tongue, soft palate and lateral pharyngeal walls. The walls are a complex structure made up of a number of muscles including the hypoglossus, styloglossus, stylohyoid, stylopharyngeus, palatoglossus, palatopharyngeus, the pharyngeal constrictors, lymphoid tissue (palatine tonsils), and pharyngeal mucosa. The biomechanical relationships between these muscles and the way they interact with the soft palate and tongue are not well understood, nor is it understood how the lateral pharyngeal wall moves during respiration or during apnea to modulate airway size.
Whether the airway actually collapses laterally or A-P is not discussed in the literature. MR anatomical studies demonstrate posterior movement and thickening of the soft palate with sleep as well as lateral pharyngeal wall thickening. Trudo FJ et al., State-related Changes in Upper Airway Caliber and Surrounding Soft-Tissue Structures in Normal Subjects. Am J Respir Crit Care Med 1998; 158:1259-1270. Other studies have shown that increasing increment levels of effective CPAP therapy results in increased airway volume and area within the retropalatal and retroglossal regions, greater lateral than A-P airway dimensional changes, a decrease in the lateral pharyngeal wall thickness, and an increase in the distance between the lateral pharyngeal fat pads. Schwab RJ, Functional Properties of the Pharyngeal Air-way. Sleep 1996; 19(10):S170-S174. Furthermore, effective mandible repositioning devices have been shown to thin the lateral pharyngeal walls; it is theorized that these devices may put traction on the lateral walls, resulting in the thinning of the walls. Subsequently, designing a device that affects the lateral pharyngeal walls seems appropriate in effectively addressing OSA.
An effective device preferably establishes a pressure differential of 8 cm H20 between nasal pressure and pharyngeal critical pressure (Pcπt) to eliminate obstructive sleep apnea and snoring. The critical pressure is defined as the pressure that is equal to the pressures exerted on the airway by the surrounding tissue which is equal to the pressures tending to collapse the airway See, Gold AR, Schwartz AR, The Pharyngeal Critical Pressure. Chest 1996; 110:1077-88. It is determined by finding the level of nasal pressure below which maximal inspiratory airflow ceases (airway collapse). Schwarz AR et al., Effect of Uvulopalatopharyngoplasty on
Upper Airway CoUapsibihty in Obstructive Sleep Apnea. Am Rev Respir Dis 1992; 145(3): 527-532.
A higher Pcπt equates to an increase in coUapsibihty. The PCrit for normal people is < - 8 cm H20. For snorers the Pcπt is approximately - 4 cm H2O, and for those with OSA (obstructive sleep apnea), the Pcπt is approximately 0 cm H20. See, Gold AR, supra.
The implant should be able to withstand a pressure of 4.4 cm H2O to prevent collapse. This was the upper airway suction closing pressure found in OSA patient studies by Issa FQ, Sullivan CE, Upper Airway Closing Pressures in Obstructive Sleep Apnea. J Appl Physiol 1984; 57(2):520-527. Studies have shown that by sleeping with one's mouth open, a 4 cm H2O increase in Pcrjt can occur. See, Gold AR, Schwartz AR, The Pharyngeal Critical Pressure. Chest 1996; 110:1077-88. Effective UPPP surgery has demonstrated a reduction in Pcrit from -0.8 to -7.3 cm H O. Schwarz AR et al., Effect of Uvulopalatopharyngoplasty on Upper Airway Collapsibility in Obstructive Sleep Apnea. Am Rev Respir Dis 1992; 145(3): 527- 532.
Normal individuals maintain a positive pharyngeal transmural pressure of approximately 0 to 10 mm Hg (13.6 cm H2O) during sleep. In contrast, upper airway obstruction in apneics is associated with development of negative transmural pressure during sleep. Clinically significant levels of obstructive sleep apnea can be produced when a nasal pressure of -10 cm H O is applied to normal subjects during sleep. These findings suggest that a disturbance in reflex responses is not necessary for the development of recurrent obstructive apneas (as some literature suggests). Rather, structural or neuromuscular factors that decrease the pharyngeal transmural pressure will predispose to this disorder. King ED, O'Donnell CP, Smith PL, Schwartz AR, A Model of Obstructive Sleep Apnea in Normal Humans. Am J Respir Crit Care Med 2000; 161:1979-1984. The dynamic biomechanical relationships between the upper airway muscles that allow physiologic functions like vocalization, swallowing, and respiration to occur is complex. Schwab RJ, Upper Airway Imaging. Clinics in Chest Medicine 1998; 19(l):33-54. In the pharyngeal phase of swallowing, more than two dozen muscles are required to function together to effectively transport a bolus from the mouth to the esophagus. The posterior pharyngeal wall movement has been studied by Palmer et al., there is considerable mobility normally present in the posterior pharyngeal wall (retropalatal and retroglossal). Palmer JB et al. Motions of the Posterior Pharyngeal Wall in Swallowing, Laryngoscope 1999; 98:414-417.
The implant is sized to be implantable in a typical apneic based upon the following anatomical measurements (Schwab RJ et al., Upper Airway and Soft
Tissue Anatomy in Normal Subjects and Patients with Sleep-Disordered Breathing. Am J Respir Crit Care Med 1995; 152:1673-1689): a. thickness of lateral pharyngeal wall: (approx 30 mm) b. anterior-posterior diameter of airway: (4.7 +/- 2.5 mm) a. lateral diameter of airway (6.7 +/- 4.5 mm) at the level of the minimum airway area in apneics. The foregoing describes numerous embodiments of a method and apparatus to treat a pharyngeal wall. Having described the invention, alternatives and embodiments may occur to one of skill in the art. For example, while placing one or more implants 110 in the pharyngeal wall partially extending around the circumference of the pharyngeal, is a presently preferred embodiment, other alternatives exist. For example, implants 110' can be placed in pharyngeal wall parallel to the axis of the pharyngeal airway and spaced around the circumference of the pharyngeal wall as shown in Figures 9 and 10. Also alternatively, a sheet of polyester material 110" (or other fibrosis-inducing material) can be placed in the pharyngeal wall at least partially surrounding the axis as shown in Figure 11. In all embodiments, any stiffness of the material and any resulting fibrosis add structural integrity to the pharyngeal wall. It is intended that such modifications and equivalents shall be included within the scope of the following claims.

Claims

What is claimed is:
1. A method for treating a pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining said airway, said method comprising: selecting an implant dimensioned so as to be implanted beneath a mucosal layer of said pharyngeal wall and extending transverse to said wall; said implant having mechanical characteristics for said implant, at least in combination with a fibrotic tissue response induced by said implant, to stiffen aid pharyngeal wall to resist radial collapse; and implanting said implant into said pharyngeal wall.
2. A method according to claim 1 wherein said implant is implanted transverse to a longitudinal axis of said airway.
3. A method according to claim 2 wherein multiple ones of said implant are implanted transverse to said longitudinal axis with said multiple ones spaced along said axis.
4. A method according to claim 1 wherein said implant is implanted substantially parallel to a longitudinal axis of said airway.
5. A method according to claim 4 wherein multiple ones of said implant are implanted substantially parallel to said longitudinal axis with said multiple ones spaced along a circumference of said pharyngeal wall.
6. A method according to claim 1 wherein said implant is placed within a mucosal layer of said pharyngeal wall and extending transverse to said wall.
7. A method according to claim 1 comprising: selecting an implant having a longitudinal dimension and a narrower transverse dimension and said implant being flexible along said longitudinal dimension, said implant further dimensioned so as to not substantially increase a bulk of pharyngeal wall following implantation of said implant into said pharyngeal wall; and implanting said implant within said pharyngeal wall with said longitudinal dimension extending in a path at least partially circumferentially surrounding a longitudinal axis of said airway.
8. An apparatus for treating a pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining said airway, said apparatus comprising: an implant of bio-compatible material sized to be embedded within said pharyngeal wall; and said implant selected to have a stiffness to stiffen said pharyngeal wall after implantation in said pharyngeal wall, to resist radial collapse of said wall.
9. An apparatus according to claim 8 wherein said implant is flexible along a longitudinal dimension.
10. An apparatus according to claim 9 wherein said implant includes a surface adapted for tissue in-growth.
11. An apparatus according to claim 10 wherein at least an outer surface of said implant is a polyester.
12. An apparatus according to claim 9 wherein said implant is elastic to be biased toward a rest position following bending of said implant along said longitudinal axis.
13. An apparatus according to claim 8 wherein said implant includes a radiopaque marking.
14. A method for treating a pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining said airway, said method comprising: inserting an expander member into said airway and positioning an active portion of said expander member in opposition to portions of said wall to be treated; activating said expander member to urge said portions outwardly to an outwardly displaced position; deactivating said expander member while leaving said portions in said outwardly placed position; and removing said expander member from said airway.
15. A method according to claim 14 wherein said activating of said expander member creates an area of compressed tissue of said patient adjacent said portions and said method further comprising injecting a biocompatible tissue stabilizer into said compressed tissue while said portions are in said outwardly placed positions.
16. A method according to claim 15 wherein said removing of said expander member occurs after at least initial setting of said adhesive.
17. A method according to claim 15 further comprising injecting a fibrosis- inducing agent into said compressed tissue to induce a fibrotic response from said compressed tissue.
18. A method according to claim 16 wherein said fibrosis-inducing agent is substantially non-biodegradable for said agent to induce a chronic fibrotic response.
19. A method according to claim 18 wherein said fibrosis-inducing agent is a bolus of particulate material.
20. A method according to claim 14 further comprising injecting a fibrosis- inducing agent into said compressed tissue to induce a fibrotic response from said compressed tissue.
21. A method according to claim 20 wherein said fibrosis-inducing agent is substantially non-biodegradable for said agent to induce a chronic fibrotic response.
22. A method according to claim 21 wherein said fibrosis-inducing agent is a bolus of particulate material.
23. A method for treating a pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining said airway, said method comprising stabilizing at least a portion of said wall against underlying structure by securing said portion to said structure.
24. A method according to claim 23 wherein said stabilization includes mechanically securing said portion to said structure.
25. A method according to claim 24 wherein said stabilization includes suturing said portion to said structure.
26. A method according to claim 23 wherein said stabilization includes adhering said portion to said structure.
27. A method according to claim 23 further comprising compressing said portion prior to said stabilization.
28. A method for treating a pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining said airway, said method comprising: compressing at least a portion of said wall to a compressed state; and stabilizing said portion in said compressed state.
29. A method according to claim 28 wherein said stabilization includes mechanically securing said portion to a structure underlying said wall.
30. A method according to claim 29 wherein said stabilization includes suturing said portion to a structure underlying said wall.
31. A method according to claim 28 wherein said stabilization includes adhering said portion to a structure underlying said wall.
32. An apparatus for treating a pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining said airway, said method comprising; an expander member dimensioned so as to be inserted into said airway with an active portion of said expander member positioned in opposition to portions of said wall to be treated; an activator for activating said expander member to urge said portions outwardly to an outwardly displaced position; said expander member adapted to be deactivated while leaving said portions in said outwardly placed position; said expander member further dimensioned so as to be removable from said airway.
33. An apparatus according to claim 32 wherein said expander member includes a fluid inflatable member and said activator includes a connection between said fluid inflatable member and a source of fluid under pressure.
34. An apparatus according to claim 32 wherein said expander member includes an injector for injecting a biocompatible adhesive into compressed tissue adjacent said portions while said portions are in said outwardly placed positions.
35. An apparatus according to claim 32 further comprising an injector for injecting a fibrosis-inducing agent into compressed tissue adjacent said portions while said portions are in said outwardly placed positions.
36. An apparatus according to claim 35 wherein said fibrosis-inducing agent is substantially non-biodegradable.
37. An apparatus according to claim 36 wherein said expander member carries a bolus of a particulate material as said fibrosis-inducing agent.
PCT/US2003/003503 2002-02-04 2003-02-04 Stiffening pharyngeal wall treatment WO2003065947A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003209005A AU2003209005A1 (en) 2002-02-04 2003-02-04 Stiffening pharyngeal wall treatment

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/066,967 2002-02-04
US10/066,967 US7146981B2 (en) 2002-02-04 2002-02-04 Pharyngeal wall treatment
US10/237,149 2002-09-06
US10/237,149 US7017582B2 (en) 2002-02-04 2002-09-06 Stiffening pharyngeal wall treatment

Publications (1)

Publication Number Publication Date
WO2003065947A1 true WO2003065947A1 (en) 2003-08-14

Family

ID=27736785

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/003503 WO2003065947A1 (en) 2002-02-04 2003-02-04 Stiffening pharyngeal wall treatment

Country Status (3)

Country Link
US (4) US7017582B2 (en)
AU (1) AU2003209005A1 (en)
WO (1) WO2003065947A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7836888B2 (en) 2004-09-21 2010-11-23 Pavad Medical, Incorporated Airway implant and methods of making and using
US7882842B2 (en) 2004-09-21 2011-02-08 Pavad Medical, Inc. Airway implant sensors and methods of making and using the same
US8167787B2 (en) 2008-01-03 2012-05-01 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8327854B2 (en) 2008-05-12 2012-12-11 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8578937B2 (en) 2004-09-21 2013-11-12 Medtronic Xomed, Inc. Smart mandibular repositioning system
US8733363B2 (en) 2010-03-19 2014-05-27 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US8776799B2 (en) 2010-03-19 2014-07-15 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9439801B2 (en) 2012-06-29 2016-09-13 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9510922B2 (en) 2010-05-21 2016-12-06 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9707122B2 (en) 2010-07-26 2017-07-18 Revent Medical, Inc. Systems and methods for treatment of sleep apnea

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962904B1 (en) * 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US7419949B2 (en) * 2001-07-16 2008-09-02 Novo Noridsk Healthcare A/G Single-dose administration of factor VIIa
US7146981B2 (en) 2002-02-04 2006-12-12 Restore Medical, Inc. Pharyngeal wall treatment
US7017582B2 (en) * 2002-02-04 2006-03-28 Restore Medical Inc. Stiffening pharyngeal wall treatment
US8807137B2 (en) * 2002-09-06 2014-08-19 Koninklijke Philips N.V. Self-anchoring magnetic force implant devices, systems, and methods
EP1545387A1 (en) * 2002-10-04 2005-06-29 Stephen N. Brooks System and method for preventing closure of passageways
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
EP1514525B1 (en) * 2003-09-12 2008-03-19 Mahlo, Hans-Wolfgang, Dr. med. Prosthesis for introducing into the throat of a living being
CA2544304A1 (en) * 2003-11-05 2005-05-26 Pavad Medical, Inc. Electrically activated alteration of body tissue stiffness for breathing disorders
JP2007512090A (en) * 2003-11-20 2007-05-17 アプネオン,インコーポレイテッド Device, system and method for anchoring tissue in a body region such as a pharyngeal conduit
US8821495B2 (en) * 2003-12-15 2014-09-02 Koninklijke Philips N.V. System and method for hyoidplasty
US8080014B2 (en) 2004-12-15 2011-12-20 Koninklijke Philips Electronics N.V. System and method for hyoidplasty
US7540699B2 (en) * 2004-04-15 2009-06-02 Stafast Products, Inc. Adjustable threshold fastener with flanges
US8813753B2 (en) * 2004-09-21 2014-08-26 Medtronic Xomed, Inc. Implantable obstructive sleep apnea sensor
US7997266B2 (en) * 2004-10-04 2011-08-16 Koninklijke Philips Electronics N.V. System and method for airway manipulation
US8096303B2 (en) 2005-02-08 2012-01-17 Koninklijke Philips Electronics N.V Airway implants and methods and devices for insertion and retrieval
US7992567B2 (en) 2005-02-08 2011-08-09 Koninklijke Philips Electronics N.V. System and method for percutaneous glossoplasty
US8371307B2 (en) 2005-02-08 2013-02-12 Koninklijke Philips Electronics N.V. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US20070144534A1 (en) * 2005-11-30 2007-06-28 Carlos Mery System to prevent airway obstruction
EP2037850A2 (en) 2006-07-06 2009-03-25 Quiescence Medical Inc Apparatus and methods for treating sleep apnea
US7780730B2 (en) 2006-09-25 2010-08-24 Iyad Saidi Nasal implant introduced through a non-surgical injection technique
US20080223367A1 (en) * 2007-01-29 2008-09-18 Cox Brian J Method and apparatus for treating airway obstruction
WO2009072115A2 (en) * 2007-12-05 2009-06-11 Svip 7 Llc Devices and methods for treating sleep disordered breathing
US7954494B1 (en) 2008-03-26 2011-06-07 Connor Robert A Device with actively-moving members that hold or move the tongue
US8678008B2 (en) 2008-07-30 2014-03-25 Ethicon, Inc Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US8556797B2 (en) * 2008-07-31 2013-10-15 Ethicon, Inc. Magnetic implants for treating obstructive sleep apnea and methods therefor
US8413661B2 (en) * 2008-08-14 2013-04-09 Ethicon, Inc. Methods and devices for treatment of obstructive sleep apnea
US20100185049A1 (en) * 2008-10-22 2010-07-22 Allergan, Inc. Dome and screw valves for remotely adjustable gastric banding systems
US20100100170A1 (en) * 2008-10-22 2010-04-22 Boston Scientific Scimed, Inc. Shape memory tubular stent with grooves
US8561616B2 (en) 2008-10-24 2013-10-22 Ethicon, Inc. Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea
US8561617B2 (en) * 2008-10-30 2013-10-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
WO2010059586A1 (en) 2008-11-19 2010-05-27 Entrigue Surgical, Inc. Apparatus and methods for correcting nasal valve collapse
US8800567B2 (en) * 2008-12-01 2014-08-12 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8783258B2 (en) * 2008-12-01 2014-07-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8371308B2 (en) * 2009-02-17 2013-02-12 Ethicon, Inc. Magnetic implants and methods for treating an oropharyngeal condition
US8307831B2 (en) 2009-03-16 2012-11-13 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8371300B2 (en) * 2009-04-24 2013-02-12 New York University System and method for circuits to allow CPAP to provide zero pressure
US9326886B2 (en) * 2009-10-29 2016-05-03 Ethicon, Inc. Fluid filled implants for treating obstructive sleep apnea
US9877862B2 (en) * 2009-10-29 2018-01-30 Ethicon, Inc. Tongue suspension system with hyoid-extender for treating obstructive sleep apnea
US9974683B2 (en) 2009-10-30 2018-05-22 Ethicon, Inc. Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea
US8632488B2 (en) 2009-12-15 2014-01-21 Ethicon, Inc. Fluid filled implants for treating medical conditions
US9833353B2 (en) * 2010-06-03 2017-12-05 Koninklijke Philips N.V. Glossoplasty implant tension relief system
US9265649B2 (en) 2010-12-13 2016-02-23 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US9084859B2 (en) 2011-03-14 2015-07-21 Sleepnea Llc Energy-harvesting respiratory method and device
US11241271B2 (en) 2011-06-14 2022-02-08 Aerin Medical Inc. Methods of treating nasal airways
US8986301B2 (en) 2012-06-13 2015-03-24 Aerin Medical Inc. Methods and devices to treat nasal airways
US8936594B2 (en) 2011-06-14 2015-01-20 Aerin Medical Inc. Methods and devices to treat nasal airways
US10722282B2 (en) 2011-06-14 2020-07-28 Aerin Medical, Inc. Methods and devices to treat nasal airways
US9415194B2 (en) 2011-06-14 2016-08-16 Aerin Medical Inc. Post nasal drip treatment
US10456185B2 (en) 2011-06-14 2019-10-29 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11033318B2 (en) 2011-06-14 2021-06-15 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11304746B2 (en) 2011-06-14 2022-04-19 Aerin Medical Inc. Method of treating airway tissue to reduce mucus secretion
US8905033B2 (en) 2011-09-28 2014-12-09 Ethicon, Inc. Modular tissue securement systems
US9161855B2 (en) 2011-10-24 2015-10-20 Ethicon, Inc. Tissue supporting device and method
US8973582B2 (en) 2011-11-30 2015-03-10 Ethicon, Inc. Tongue suspension device and method
US10470760B2 (en) 2011-12-08 2019-11-12 Ethicon, Inc. Modified tissue securement fibers
US9173766B2 (en) 2012-06-01 2015-11-03 Ethicon, Inc. Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients
CA2888030A1 (en) 2012-10-16 2014-11-27 Cook Medical Technologies Llc Method and apparatus for treating obstructive sleep apnea (osa)
US9480594B2 (en) 2013-02-27 2016-11-01 Spirox, Inc. Nasal implants and systems and methods of use
US9855164B2 (en) * 2013-03-06 2018-01-02 Ethicon, Inc. Method and device for treating obstructive sleep apnea
AU2014306232B2 (en) 2013-08-05 2018-12-06 Cook Medical Technologies Llc Medical devices having a releasable tubular member and methods of using the same
US9687288B2 (en) 2013-09-30 2017-06-27 Arrinex, Inc. Apparatus and methods for treating rhinitis
US9974563B2 (en) 2014-05-28 2018-05-22 Cook Medical Technologies Llc Medical devices having a releasable member and methods of using the same
US9918858B2 (en) 2014-05-30 2018-03-20 Boston Scientific Scimed, Inc. Endoluminal stents and methods of delivery
US9763743B2 (en) 2014-07-25 2017-09-19 Arrinex, Inc. Apparatus and method for treating rhinitis
EP3177219B1 (en) 2014-08-04 2018-09-26 Cook Medical Technologies LLC Medical devices having a releasable tubular member
WO2016033196A1 (en) 2014-08-26 2016-03-03 Spirox, Inc. Nasal implants and systems and method of use
CN108024825B (en) 2015-09-25 2021-07-30 斯贝洛克斯公司 Nasal implants and systems and methods of use
AU2017217934B2 (en) 2016-02-12 2021-02-18 Aerin Medical, Inc. Hyaline cartilage shaping
EP3422965B1 (en) 2016-03-04 2019-12-11 Aerin Medical, Inc. Device for eustachian tube modification
EP3451894B1 (en) 2016-05-02 2023-11-15 Entellus Medical, Inc. Nasal valve implants
CN110290767A (en) 2016-12-22 2019-09-27 艾琳医药股份有限公司 Soft palate treatment
US11806071B2 (en) 2016-12-22 2023-11-07 Aerin Medical Inc. Soft palate treatment
JP7300999B2 (en) 2017-04-28 2023-06-30 アリネックス, インコーポレイテッド Systems and methods for locating blood vessels in the treatment of rhinitis
USD880694S1 (en) 2017-05-01 2020-04-07 Aerin Medical, Inc. Nasal airway medical instrument
US11096738B2 (en) 2017-05-05 2021-08-24 Aerin Medical, Inc. Treatment of spinal tissue
USD902412S1 (en) 2018-10-31 2020-11-17 Aerin Medical, Inc. Electrosurgery console
USD881904S1 (en) 2018-10-31 2020-04-21 Aerin Medical Inc. Display screen with animated graphical user interface
EP4164550A1 (en) 2020-06-10 2023-04-19 The Board of Trustees of the Leland Stanford Junior University Systems and methods for altering the shape of nasal tissues

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5979456A (en) * 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
DE19920114A1 (en) * 1999-05-03 2000-11-09 Fege Wolfgang Throat side implant
US20010037133A1 (en) * 1999-09-17 2001-11-01 Knudson Mark B. Braided palatal implant for snoring treatment

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US36120A (en) * 1862-08-05 Improvement in cutters for sugar-cane, sorghum
US3998209A (en) * 1975-12-16 1976-12-21 Macvaugh Gilbert S Snoring deconditioning system and method
US4553540A (en) 1983-08-16 1985-11-19 Straith Richard E Airway
US4792336A (en) 1986-03-03 1988-12-20 American Cyanamid Company Flat braided ligament or tendon implant device having texturized yarns
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4830008A (en) * 1987-04-24 1989-05-16 Meer Jeffrey A Method and system for treatment of sleep apnea
SU1553140A1 (en) 1988-06-15 1990-03-30 Пермский государственный медицинский институт Method of electric stimulation of soft palate muscles
US5258028A (en) * 1988-12-12 1993-11-02 Ersek Robert A Textured micro implants
US5181505A (en) * 1989-03-08 1993-01-26 Lew Chel W Method and apparatus for delivery of a medicament in the oral cavity
CA1332905C (en) * 1989-03-10 1994-11-08 John A. Murchie Method and apparatus for treatment of snoring
US5052409A (en) * 1989-05-08 1991-10-01 Tepper Harry W Oral appliance for tongue thrust correction
US4990158A (en) 1989-05-10 1991-02-05 United States Surgical Corporation Synthetic semiabsorbable tubular prosthesis
JP2794196B2 (en) * 1989-06-20 1998-09-03 チェスト株式会社 Apnea prevention stimulator
US5176618A (en) * 1989-08-10 1993-01-05 George Freedman System for preventing closure of passageways
US4978323A (en) * 1989-08-10 1990-12-18 George Freedman System and method for preventing closure of passageways
US5133354A (en) * 1990-11-08 1992-07-28 Medtronic, Inc. Method and apparatus for improving muscle tone
US5158080A (en) * 1990-11-08 1992-10-27 Medtronic, Inc. Muscle tone
US5190053A (en) * 1991-02-28 1993-03-02 Jeffrey A. Meer, Revocable Living Trust Method and apparatus for electrical sublingual stimulation
US5204382A (en) * 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
JPH0795636B2 (en) * 1992-06-16 1995-10-11 昭和アルミニウム株式会社 Manufacturing method of radiator with pin fins
US5456662A (en) * 1993-02-02 1995-10-10 Edwards; Stuart D. Method for reducing snoring by RF ablation of the uvula
US5514131A (en) * 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
US5494029A (en) * 1992-09-29 1996-02-27 Hood Laboratories Laryngeal stents
US5284161A (en) * 1992-11-12 1994-02-08 Karell Manuel L Snopper-the snoring stopper anti-snoring mouth device
US5443063A (en) 1993-08-31 1995-08-22 The Johns Hopkins University Cuffed oro-pharyngeal airway
US5582184A (en) 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
DE4412190A1 (en) 1994-04-08 1995-10-12 Schreiber Hans Prevention of snoring
US5674191A (en) * 1994-05-09 1997-10-07 Somnus Medical Technologies, Inc. Ablation apparatus and system for removal of soft palate tissue
US5843021A (en) * 1994-05-09 1998-12-01 Somnus Medical Technologies, Inc. Cell necrosis apparatus
US5897579A (en) * 1994-09-15 1999-04-27 Mount Sinai School Of Medicine Method of relieving airway obstruction in patients with bilateral vocal impairment
US5540733A (en) * 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for detecting and treating obstructive sleep apnea
US5549655A (en) 1994-09-21 1996-08-27 Medtronic, Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
NO301210B1 (en) * 1994-12-14 1997-09-29 Camtech As Use of sensors to measure an individual's respiration time volume
US5591216A (en) * 1995-05-19 1997-01-07 Medtronic, Inc. Method for treatment of sleep apnea by electrical stimulation
JPH09138808A (en) * 1995-11-15 1997-05-27 Kureha Chem Ind Co Ltd Display method for compound reaction route figure
US5792067A (en) * 1995-11-21 1998-08-11 Karell; Manuel L. Apparatus and method for mitigating sleep and other disorders through electromuscular stimulation
US5791341A (en) * 1995-12-19 1998-08-11 Bullard; James Roger Oropharyngeal stent with laryngeal aditus shield and nasal airway with laryngeal aditus shield
US5669377A (en) * 1996-07-05 1997-09-23 Fenn; Arthur C. Nasal band and method for improved breathing
US5792478A (en) * 1996-07-08 1998-08-11 Advanced Uro Science Tissue injectable composition and method of use
US5922006A (en) * 1996-08-12 1999-07-13 Sugerman; Joseph H. Nasal appliance
DE69718495T2 (en) * 1996-09-17 2003-11-20 Deka Products Lp SYSTEM FOR DISPOSAL OF MEDICINE BY TRANSPORT
US5853004A (en) * 1997-06-02 1998-12-29 Goodman; Evan J. Pharyngeal bulb airway
US5988171A (en) * 1997-06-26 1999-11-23 Influence Medical Technologies, Ltd. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
JP3664463B2 (en) 1997-07-15 2005-06-29 川澄化学工業株式会社 Esophageal catheter
US5957133A (en) 1997-07-21 1999-09-28 Hart; William T. Oral appliance with negative air supply for reducing sleep apnea and snoring
DE19756956C1 (en) 1997-12-20 1999-07-15 Wolfgang Dr Med Fege Implant for implantation in a tongue
US6161541A (en) 1998-06-09 2000-12-19 Influent Ltd. Hyoid expansion and suspension procedure
US6591838B2 (en) * 1998-07-06 2003-07-15 Scimed Life Systems, Inc. Implant system and method for bulking tissue
US6240316B1 (en) * 1998-08-14 2001-05-29 Advanced Bionics Corporation Implantable microstimulation system for treatment of sleep apnea
US6196224B1 (en) 1998-09-30 2001-03-06 David D. Alfery Perilaryngeal oral airway
US6098629A (en) * 1999-04-07 2000-08-08 Endonetics, Inc. Submucosal esophageal bulking device
US6183493B1 (en) 1999-08-24 2001-02-06 Pharmasys International, Llc Method and apparatus for the treatment of sleep apnea and related breathing disorders
US6390096B1 (en) 1999-09-17 2002-05-21 Pi Medical, Inc. Needle with pre-loaded implant for snoring treatment
US6431174B1 (en) * 2000-08-10 2002-08-13 Pi Medical, Inc. Method and apparatus to treat conditions of the naso-pharyngeal area
US6250307B1 (en) * 1999-09-17 2001-06-26 Pi Medical, Inc. Snoring treatment
US6636767B1 (en) 1999-09-29 2003-10-21 Restore Medical, Inc. Implanatable stimulation device for snoring treatment
US6722360B2 (en) 2000-06-16 2004-04-20 Rajiv Doshi Methods and devices for improving breathing in patients with pulmonary disease
US20020049479A1 (en) * 2000-10-20 2002-04-25 Pitts Walter C. Method and apparatus for creating afferents to prevent obstructive sleep apnea
US6748950B2 (en) * 2001-04-30 2004-06-15 Closure Medical Corporation Compositions and medical procedure to treat snoring
US6746950B2 (en) * 2001-11-14 2004-06-08 Vitesse Semiconductor Corporation Low temperature aluminum planarization process
US7017582B2 (en) 2002-02-04 2006-03-28 Restore Medical Inc. Stiffening pharyngeal wall treatment
US7146981B2 (en) 2002-02-04 2006-12-12 Restore Medical, Inc. Pharyngeal wall treatment
ATE427724T1 (en) 2002-09-06 2009-04-15 Koninkl Philips Electronics Nv SYSTEMS FOR MOVING AND/OR RETENTION TISSUE IN THE UPPER AIRWAYS
US7216648B2 (en) * 2002-09-06 2007-05-15 Apneon, Inc. Systems and methods for moving and/or restraining tissue in the upper respiratory system
US7360542B2 (en) * 2002-09-06 2008-04-22 Apneon, Inc. Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
US7188627B2 (en) * 2002-09-06 2007-03-13 Apneon, Inc. Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit
CA2497666A1 (en) 2002-09-06 2004-03-18 Apneon, Inc. Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngal conduit
US7992566B2 (en) * 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
EP1596805A2 (en) * 2003-01-15 2005-11-23 Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California Treatments for snoring using injectable neuromuscular stimulators
BRPI0507224A (en) 2004-02-26 2007-06-19 Iras Sanders method and device for the treatment of obstructive sleep apnea and snoring
DE102005000702B4 (en) 2005-01-04 2007-08-23 Klinikum Der Universität Regensburg Device for central implantation in a tongue body

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5979456A (en) * 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
DE19920114A1 (en) * 1999-05-03 2000-11-09 Fege Wolfgang Throat side implant
US20010037133A1 (en) * 1999-09-17 2001-11-01 Knudson Mark B. Braided palatal implant for snoring treatment

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7836888B2 (en) 2004-09-21 2010-11-23 Pavad Medical, Incorporated Airway implant and methods of making and using
US7882842B2 (en) 2004-09-21 2011-02-08 Pavad Medical, Inc. Airway implant sensors and methods of making and using the same
US8578937B2 (en) 2004-09-21 2013-11-12 Medtronic Xomed, Inc. Smart mandibular repositioning system
US8167787B2 (en) 2008-01-03 2012-05-01 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8747296B2 (en) 2008-01-03 2014-06-10 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8523760B2 (en) 2008-01-03 2013-09-03 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8707960B2 (en) 2008-05-12 2014-04-29 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8327854B2 (en) 2008-05-12 2012-12-11 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8991398B2 (en) 2008-05-12 2015-03-31 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8733363B2 (en) 2010-03-19 2014-05-27 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US8776799B2 (en) 2010-03-19 2014-07-15 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9381109B2 (en) 2010-03-19 2016-07-05 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9510922B2 (en) 2010-05-21 2016-12-06 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9707122B2 (en) 2010-07-26 2017-07-18 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9439801B2 (en) 2012-06-29 2016-09-13 Revent Medical, Inc. Systems and methods for treatment of sleep apnea

Also Published As

Publication number Publication date
US8037885B2 (en) 2011-10-18
US20120031412A1 (en) 2012-02-09
US20040172054A1 (en) 2004-09-02
US20030149488A1 (en) 2003-08-07
US7322993B2 (en) 2008-01-29
AU2003209005A1 (en) 2003-09-02
US20050251255A1 (en) 2005-11-10
US8413662B2 (en) 2013-04-09
US7017582B2 (en) 2006-03-28

Similar Documents

Publication Publication Date Title
US8037885B2 (en) Treatment for sleep apnea or snoring
US8864788B2 (en) Pharyngeal wall treatment
EP1309299B1 (en) Apparatus to treat conditions of the naso-pharyngeal area
US20050121039A1 (en) Altering the stiffness, size and/or shape of tissues for breathing disorders and other conditions
WO2003041612A2 (en) Lateral stiffening snoring treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP